BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7033830)

  • 1. [Treatment of refractory arterial hypertension with a converting enzyme inhibiting drug (Captopril)].
    Lavezzaro GC; Angelino PF; Gastaldo D; Minelli M; Paccotti P; Angeli A
    Minerva Cardioangiol; 1981 Oct; 29(10):519-25. PubMed ID: 7033830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A; Aguglia F; Ficara C
    Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of captopril in periarteritis nodosa with arterial hypertension and renal failure (author's transl)].
    Guillevin L; Leenhardt A; Herson S; Bletry O; Godeau P
    Nouv Presse Med; 1981 Apr; 10(19):1592-3. PubMed ID: 6116493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of captopril on arterial pressure, plasma renin activity and the autonomic nervous system in essential arterial hypertension with low-normal plasma renin activity].
    Sturani A; Chiarini C; Degli Esposti E; Gattiani A; Masi A; Santoro A; Umile A; Zuccalà A; Zucchelli P
    Minerva Nefrol; 1981; 28(3):265-9. PubMed ID: 7036015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 11. [Captopril in severe arterial hypertension of childhood (authors transl)].
    Bacri JL; Dechaux M; André JL; Gagnadoux MF; Broyer M
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():887-92. PubMed ID: 7036933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of SQ 14225 in the treatment of essential arterial hypertension].
    Degli Esposti E; Chiarini C; Fusaroli M; Masi A; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1981 Apr; 97(2):153-63. PubMed ID: 6263540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of essential hypertension with primary elevated blood renin and treatment with captopril].
    Cortinovis A; Crippa A; Fioravanti C; Golia F
    Cardiologia; 1983 Mar; 28(3):227-36. PubMed ID: 6378219
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril in the treatment of refractory high-renin hypertension.
    Cutfield R; Sharpe DN; Clarke ED
    N Z Med J; 1980 Jun; 91(661):424-6. PubMed ID: 6104314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
    Watanabe H
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):405-19. PubMed ID: 6750185
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of severe refractory hypertension with captopril].
    Gabizon D; Weissgarten Y; Pik A; Modai D
    Harefuah; 1981 Oct; 101(7-8):167-9. PubMed ID: 6277749
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension in a patient with hypercalcemia: captopril and verapamil.
    Waeber B; Brunner HR; Burckhardt P; Gavras H
    Arch Intern Med; 1982 Jan; 142(1):143-5. PubMed ID: 7032443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of angiotensin I to II converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension.
    Ryan E; Muldowney FP
    Ir Med J; 1983 Apr; 76(4):175, 177-8. PubMed ID: 6345457
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension].
    Valvo E; Previato G; Oldrizzi L; Corgnati A; Lupo A; Loschiavo C; Tessitore N; Maschio G
    Minerva Nefrol; 1981; 28(2):139-41. PubMed ID: 7027091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.